PL3634461T3 - Szczepionka celująca w kryptyczny epitop tert do leczenia raka płuca u pacjenta hla-a*0201 dodatniego, będącego osobą, która nigdy nie paliła lub byłym palaczem, który palił niewiele - Google Patents
Szczepionka celująca w kryptyczny epitop tert do leczenia raka płuca u pacjenta hla-a*0201 dodatniego, będącego osobą, która nigdy nie paliła lub byłym palaczem, który palił niewieleInfo
- Publication number
- PL3634461T3 PL3634461T3 PL18729565.4T PL18729565T PL3634461T3 PL 3634461 T3 PL3634461 T3 PL 3634461T3 PL 18729565 T PL18729565 T PL 18729565T PL 3634461 T3 PL3634461 T3 PL 3634461T3
- Authority
- PL
- Poland
- Prior art keywords
- smoker
- hla
- light
- lung cancer
- patient
- Prior art date
Links
- 108010088729 HLA-A*02:01 antigen Proteins 0.000 title 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
- A61K39/001157—Telomerase or TERT [telomerase reverse transcriptase]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305527.8A EP3400954A1 (en) | 2017-05-09 | 2017-05-09 | Vaccine targeting a cryptic tert epitope, for treating lung cancer in a hla-a*0201-positive never-smoker or light-former smoker patient |
| PCT/EP2018/061609 WO2018206462A1 (en) | 2017-05-09 | 2018-05-04 | Use of a vaccine targeting a cryptic tert epitope, for treating lung cancer in a hla-a*0201-positive never-smoker or light-former smoker patient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3634461T3 true PL3634461T3 (pl) | 2024-01-29 |
Family
ID=59054042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18729565.4T PL3634461T3 (pl) | 2017-05-09 | 2018-05-04 | Szczepionka celująca w kryptyczny epitop tert do leczenia raka płuca u pacjenta hla-a*0201 dodatniego, będącego osobą, która nigdy nie paliła lub byłym palaczem, który palił niewiele |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200079819A1 (pl) |
| EP (2) | EP3400954A1 (pl) |
| JP (1) | JP7406792B2 (pl) |
| CN (1) | CN110944657A (pl) |
| CA (1) | CA3061559A1 (pl) |
| ES (1) | ES2958748T3 (pl) |
| HU (1) | HUE063049T2 (pl) |
| PL (1) | PL3634461T3 (pl) |
| WO (1) | WO2018206462A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4420677A1 (en) | 2023-02-22 | 2024-08-28 | Altevax | Vaccines against tert-positive tumors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0608768B1 (pt) * | 2005-05-09 | 2019-08-20 | Vaxon Biotech | Uso de um peptídio nativo para a produção de uma composição medicinal, processo para a obtenção in vitro de ctls com elevada avidez por um peptídio nativo e kit de vacinação |
-
2017
- 2017-05-09 EP EP17305527.8A patent/EP3400954A1/en not_active Withdrawn
-
2018
- 2018-05-04 CA CA3061559A patent/CA3061559A1/en active Pending
- 2018-05-04 EP EP18729565.4A patent/EP3634461B8/en active Active
- 2018-05-04 HU HUE18729565A patent/HUE063049T2/hu unknown
- 2018-05-04 PL PL18729565.4T patent/PL3634461T3/pl unknown
- 2018-05-04 WO PCT/EP2018/061609 patent/WO2018206462A1/en unknown
- 2018-05-04 JP JP2019561949A patent/JP7406792B2/ja active Active
- 2018-05-04 US US16/611,172 patent/US20200079819A1/en active Pending
- 2018-05-04 CN CN201880030509.7A patent/CN110944657A/zh active Pending
- 2018-05-04 ES ES18729565T patent/ES2958748T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020520349A (ja) | 2020-07-09 |
| CN110944657A (zh) | 2020-03-31 |
| JP7406792B2 (ja) | 2023-12-28 |
| ES2958748T3 (es) | 2024-02-14 |
| US20200079819A1 (en) | 2020-03-12 |
| HUE063049T2 (hu) | 2023-12-28 |
| EP3634461A1 (en) | 2020-04-15 |
| EP3400954A1 (en) | 2018-11-14 |
| WO2018206462A1 (en) | 2018-11-15 |
| EP3634461B1 (en) | 2023-07-05 |
| EP3634461B8 (en) | 2023-08-02 |
| CA3061559A1 (en) | 2018-11-15 |
| EP3634461C0 (en) | 2023-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE054964T2 (hu) | Pirazol-heteroaril készítmény, az elõállítás módja és gyógyászati felhasználása | |
| IL253712B (en) | Mysterlein derivatives for coupling and healing | |
| IL260684B (en) | Treatment to regulate the microbiota in the intestine | |
| PH12016501841A1 (en) | Immunosuppressant formulation | |
| AU201812272S (en) | Nicotine Inhaler | |
| MX2017002489A (es) | Agentes terapeuticos humanos. | |
| PH12017501625A1 (en) | Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | |
| IN2014MU00303A (pl) | ||
| MX2016011295A (es) | Terapia para cancer con anticuerpos anti-met en combinacion con anti-vegfr2. | |
| IL291601A (en) | Neoglycoconjugates as vaccines and therapeutic tools | |
| SG11202004292PA (en) | Medicine for tissue regeneration, and preparation method therefor | |
| TW201713323A (en) | Therapeutic compositions and methods of use thereof | |
| EP3634461C0 (en) | VACCINE TARGETING A CRYPTIC TERT-EPITOPE FOR THE TREATMENT OF LUNG CANCER IN AN HLA-A*0201 POSITIVE PATIENT WHO HAS NEVER SMOKED OR SMOKED LESS | |
| ZA201707371B (en) | Cannula device, artificial lung | |
| EP3305263A4 (en) | INTEGRATED BED FOR ORIENTAL MEDICINAL THERAPY | |
| IL249484A0 (en) | Preparation methods for novel creation of biologically safe klh products used in cancer therapy, development of conjugated therapeutics and as challenge agents | |
| IL249483B (en) | Preparation methods for novel creation of biologically safe klh products used in cancer therapy, development of conjugated therapeutics and as challenge agents | |
| EP3411088C0 (en) | IMPLANTABLE MEDICAL PRODUCTS, PROCESS FOR THEIR MANUFACTURE AND THEIR USE | |
| AU201812271S (en) | Nicotine Inhaler | |
| AU201812270S (en) | Nicotine Inhaler | |
| AU201812269S (en) | Nicotine Inhaler | |
| AU201812268S (en) | Nicotine Inhaler | |
| GB201420777D0 (en) | Electronic cigarette , Medical drug delivery applicator for the delivery of nicotine extract E-8000 |